Secondary neoplasm to non-hodgkin lymphoma treatment manifesting as a cancer of unknown primary: the first case in literature.

cancer of unknown primary immunohistochemistry secondary neoplasm

Journal

Annals of medicine and surgery (2012)
ISSN: 2049-0801
Titre abrégé: Ann Med Surg (Lond)
Pays: England
ID NLM: 101616869

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 22 01 2024
accepted: 16 02 2024
medline: 5 4 2024
pubmed: 5 4 2024
entrez: 5 4 2024
Statut: epublish

Résumé

Cancer of unknown primary (CUP) is a tumour metastasis with no detectable primary origin. A secondary neoplasm (SN) is defined as a tumour secondary to a prior tumour treatment and has no histological relation to that primary tumour. The authors report a case of a 72-year-old female patient who presented with back pain and had a history of non-Hodgkin lymphoma (NHL) treated with RCHOP 12 years ago. MRI showed a compression fracture in T5 and T7 vertebrae, while the PET/computed tomography (CT) only showed hypermetabolic lytic bone lesions in these vertebrae. Pathological examination of a biopsy of these lesions suggested metastatic breast cancer, but the mammography was normal. The above clinical description indicates that our case is a SN to RCHOP treatment manifested as a cancer of unknown origin. CUP is diagnosed when all screening procedures fail to find the original tumour. On the other hand, the literature showed that RCHOP treatment of non-Hodgkin lymphoma has a 0.68% chance of causing a SN. After an extensive literature search, we found that our case, which has the combination of both CUP and SN, is the first documented case. This case suggests that cancer patients who received chemical or radiological treatment should be screened more carefully on the long term as it is possible to developed secondary neoplasms without a primary tumour in areas difficult to diagnose with traditional screening tools.

Identifiants

pubmed: 38576933
doi: 10.1097/MS9.0000000000001881
pii: AMSU-D-24-00182
pmc: PMC10990406
doi:

Types de publication

Case Reports

Langues

eng

Pagination

2348-2351

Informations de copyright

Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

Auteurs

George Bashour (G)

Cancer Research Center.
Faculty of Medicine.

Nina Kheyrbek (N)

Cancer Research Center.
Faculty of Medicine.

Ali Dway (A)

Cancer Research Center.
Faculty of Medicine, Al-Andalus University, Tartus, Syria.

Elias Salloum (E)

Cancer Research Center.
Faculty of Medicine.

Michael Georgeos (M)

Cancer Research Center.
Departments of Oncology.

Zuheir Alshehabi (Z)

Cancer Research Center.
Pathology, Tishreen University Hospital, Latakia.

Classifications MeSH